+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or…
Taylor Gavinchuk
‘It literally cannot go tits up’ Trading stock options provide us with the opportunity to make big gains, hedge our investments, and for the sake of this piece –…
Straya As someone who had more than a few fuckups investing in the Canadian cannabis space, the idea of being able to do it all over again is wildly…
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD…
Getting into a stock before management does is basically impossible. As a retail investor, you are waiting on the sidelines while management, institutional investors, and friends & family of…
Schizophrenia In January, the Berlin-based psychedelics giant ATAI Life Sciences purchased a majority stake in Recogify – a company researching drugs to combat ailments associated with schizophrenia. The…
IPO’s come in all shapes and sizes, some are giants with billionaire support, and others don’t have a pitch deck readily available. Investors get giddy with news of…
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come…
The Wild Wild West I was skeptical when I came across a new stock exchange I had never heard of before. Through reporting on the cannabis industry I…
Brazil Red Light Holland (TRIP.CN) is going in the opposite direction of most of the psychedelics space. It’s a gamble, but if it works it pays off. …